Skip to main content

Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial

Publication ,  Conference
Kujawski, LA; Gartner, EM; Ryan, I; Griffith, K; Erba, HP
Published in: BLOOD
November 16, 2004

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2004

Volume

104

Issue

11

Start / End Page

210B / 210B

Location

San Diego, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

46th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kujawski, L. A., Gartner, E. M., Ryan, I., Griffith, K., & Erba, H. P. (2004). Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial. In BLOOD (Vol. 104, pp. 210B-210B). San Diego, CA: AMER SOC HEMATOLOGY.
Kujawski, L. A., E. M. Gartner, I. Ryan, K. Griffith, and H. P. Erba. “Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial.” In BLOOD, 104:210B-210B. AMER SOC HEMATOLOGY, 2004.
Kujawski LA, Gartner EM, Ryan I, Griffith K, Erba HP. Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial. In: BLOOD. AMER SOC HEMATOLOGY; 2004. p. 210B-210B.
Kujawski, L. A., et al. “Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial.” BLOOD, vol. 104, no. 11, AMER SOC HEMATOLOGY, 2004, pp. 210B-210B.
Kujawski LA, Gartner EM, Ryan I, Griffith K, Erba HP. Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial. BLOOD. AMER SOC HEMATOLOGY; 2004. p. 210B-210B.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2004

Volume

104

Issue

11

Start / End Page

210B / 210B

Location

San Diego, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

46th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology